Fact CheckerSign in

NCT06198166Completed

Effects of Cuevas Medek Exercises Children With Autism Spectrum Disorder

Effects of Cuevas Medek Exercises on Balance and Posture Control in Children With Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 13 Jun 2024

Brief summary (registry, in English)

Autism spectrum disorders (ASDs) describe a group of neurodevelopmental conditions in which the individuals face challenges with social engagement. This childhood disorder is characterized by core impairments in social/communication and repetitive behaviors. Autism spectrum disorder (ASD) is a lifelong disorder that occurs in approximately 1 in 68 children aged 8 years. It is primarily characterized by limited social interaction and communication, restricted interest, and stereotyped or repetitive behaviors. The motor deficits associated with ASD can relate to impairments of motor planning and control processes. This Randomized Clinical Trial will recruit the participants through non probability convenience sampling. Participants will be randomly divided into 2 groups. Two groups of children aged between 2 and 6 years, suffering from autism spectrum disorder, one for control and one for experiment. Controlled will get conventional treatment while study group will get conventional treatment with Cuevas Medak Exercises (CME). Treatment duration is of 12 weeks. Progress will be monitored every month. The frequency of recovery sessions will 3 sessions/week, and the duration of a session will 45 minutes. Patient evaluation will be made at the beginning and the end of the treatment through pediatric balance scale and posture and postural ability scale. Data will be analyzed through SPSS 25.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
26 Dec 2023
Start date
1 Dec 2023
Primary completion date
1 Feb 2024
Lead sponsor
Riphah International University
Diseases
Autism
NCT number
NCT06198166

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 1 Dec 2023 to the primary completion date, 1 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Children with planned surgical or medical surgeries during study period.

Other illness

  • Unstable medical condition.
  • History neurological disorder (seizures, epilepsy)

Other

  • Severe behavioral problems.

Who the study is looking for

  • Children with medical diagnosis of mild ASD diagnosed by CARS assessment tool with score ranges from 15 to 30.
  • Children having postural and balance problems with scoring of 8 out of 14 items of pediatric balance scale.
  • Age ranging from 2 to 6 years
  • Parental/Caregiver report of Difficulty with motor planning, motor skills and/or postural control.
  • Children who will able to follow verbal instruction and participate in exercise program.

Age in the registry: 2 years to 6 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Riphah International University
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.